GLP-1 medications initially were used to help people with diabetes improve their insulin resistance and hunger cravings.

“[GLP-1] plays a key in regulating blood sugar and body weight,” Almandoz said. “These medications work from a weight perspective by slowing gastric emptying, which helps people feel full ...

As the body of research expands on the potential of glucagon-like peptide-1 receptor agonists to address various health ...

A new clinical trial showed promising results in curbing alcohol cravings in individuals with moderate alcohol-use disorder.

It’s obvious these drugs are trimming waistlines across the nation; what may be less obvious is that they might also reshape ...

Treatment for OUD is currently dominated by opioid agonist therapies that are highly regulated due to their liability for abuse.

Ozempic, Wegovy, Saxenda, Trulicity: These and other GLP1-RA diabetes/weight-loss meds can also boost outcomes for fo ...

As demand remains high for GLP-1 drugs, primary care physicians are concerned about the risks of patients using third-party ...

Independence Blue Cross began limiting coverage of GLP-1 drugs on Jan. 1 to some medical conditions, but not obesity or weight loss.

TUESDAY, Feb. 11, 2025 (HealthDay News) -- Ozempic, Wegovy, Saxenda, Trulicity: These and other GLP1-RA diabetes/weight-loss meds can also boost outcomes for folks battling chronic kidney disease ...